Alex Ho Fai Lee

Alex Ho Fai Lee has extensive experience in the biotechnology and healthcare industry. Alex Ho Fai is currently serving as the Director of Innovative Technologies, Research at ET Healthcare since 2022 and was previously in the same role at Gator Bio from 2021 to 2022. Prior to that, they worked as an Associate Director at Gator Bio from 2021 to 2022 and as a Freelance Consultant from 2020 to 2021, providing high-level consultation on research, molecular diagnostics, and medical devices.

Before their freelance work, Alex held the position of Team Lead, Senior Staff Scientist at Siemens Healthineers from 2018 to 2020, where they led the development of diagnostic devices and novel transport media. Alex Ho Fai also worked at Theranos as a Senior Manager of Molecular Reagents Division from 2017 to 2018 and as a Team Lead of Molecular Reagents and Senior Scientist from 2011 to 2017, specializing in research and development in the biopharmaceutical and diagnostic fields.

Alex began their career at Elim Biopharmaceuticals in 2007 as an R&D Scientist and Team Lead of Peptide and Oligonucleotide Synthesis, where they managed a successful team and played a key role in developing new product lines and synthesis technologies.

Throughout their career, Alex has demonstrated proficiency in project and group management, organic synthesis, bioconjugation, and protein chemistry. Alex Ho Fai is experienced in FDA compliance and ISO regulations and has a proven track record of delivering high-quality products and services.

Alex Ho Fai Lee completed their education in a chronological manner. Alex Ho Fai first obtained a Bachelor's Degree in Chemistry from The Chinese University of Hong Kong from 1994 to 1997. Alex Ho Fai then pursued a Master's Degree in Synthetic Organic Chemistry (M. Phil.) at the same institution from 1997 to 1999. Following that, they furthered their education at The Hong Kong Polytechnic University, where they earned a Doctor of Philosophy (Ph.D.) in Synthetic Organic, Bioorganic and Medicinal Chemistry from 1999 to 2003.

Subsequently, Alex continued their research work at Stanford University as a Postdoctoral Research Scholar from 2003 to 2006. During this time, their focus was on Organic, Bioorganic, Nucleic Acid, and Modified Oligonucleotides designs. Alex Ho Fai then took another Postdoctoral Research Scholar position at the University of California, Berkeley from 2006 to 2007, specializing in Organic, Organometallic Chemistry, and Phenylenes Syntheses.

In terms of additional certifications, Alex obtained the Certified ScrumMaster CSM from the Scrum Alliance in November 2018. There is also mention of the University of California, Berkeley in the education history, but no specific degree or dates are provided for this institution.